Skip to content
UM-HMC-1
Tissue
Salivary gland, anterior buccal gland
Disease
Salivary gland mucoepidermoid carcinoma
Metastatic site
Primary tumor site (anterior buccal gland, salivary gland)
Synonyms
University of Michigan-Human Mucoepidermoid Carcinoma-1

Documents

UM-HMC-1

Cell line · Product number 305716

UM-HMC-1 is a human mucoepidermoid carcinoma cell line established from a primary salivary gland tumor of the anterior buccal gland of a 76-year-old Afric...

CA$800.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

UM-HMC-1 is a human mucoepidermoid carcinoma cell line established from a primary salivary gland tumor of the anterior buccal gland of a 76-year-old African American male patient. The line is one of the University of Michigan Human Mucoepidermoid Carcinoma (UM-HMC) panel lines. UM-HMC-1 harbors a CRTC1-MAML2 gene fusion (also designated MECT1-MAML2), which is the defining oncogenic event in the majority of mucoepidermoid carcinomas and results from a t(11;19)(q21;p13) chromosomal translocation. This fusion activates CREB target genes and Notch pathway components, driving tumor proliferation and survival.

UM-HMC-1 is applicable in studies of salivary gland mucoepidermoid carcinoma biology, CRTC1-MAML2 fusion oncogene signalling, CREB pathway activation, Notch pathway dysregulation, and therapeutic targeting of fusion-driven cancers. It is used in drug sensitivity assays, invasion and migration studies, and as part of the UM-HMC multi-line panel for comparative characterization of salivary gland tumor biology.

Tissue
Salivary gland, anterior buccal gland
Disease
Salivary gland mucoepidermoid carcinoma
Metastatic site
Primary tumor site (anterior buccal gland, salivary gland)
Applications
Salivary gland carcinoma research; CRTC1-MAML2 fusion oncogene biology; CREB/Notch pathway studies; mucoepidermoid carcinoma drug sensitivity; fusion-driven cancer biology; UM-HMC panel studies
Synonyms
  • University of Michigan-Human Mucoepidermoid Carcinoma-1

02Classification

Organism
Human
Sex
Male
Growth properties
Adherent
Biosafety level
1

03Characteristics

Morphology
Epithelial-like
Cell type
Epithelial cells
Doubling time
approx. 24 to 48 hours

04Identifiers

Citation
UM-HMC-1 (Cytion catalog number 305716)
NCBI TaxID
9606
Cellosaurus
CVCL_Y473

05Expression and susceptibility

Mutational profile
Mutation: Gene fusion, CRTC1 + HGNC, MAML2, Name(s)=CRTC1-MAML2, MECT1-MAML2.

06Handling and culture

Culture medium
DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
Accutase, 20min 37°C
Flask coating
Use Collagen coated flasks
Subculturing
Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
Split ratio
1 to 5
Seeding density
1 to 3 x 104 cells/cm2
Fluid renewal
Every 2 to 3 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
76 years
Ethnicity
African American